This application seeks renewal of support for the Vascular Biology Training Program now housed within the Center for Vascular and Inflammatory Diseases (OVID) at the University of Maryland School of Medicine in Baltimore, MD. The goals of this training program are to provide multidisciplinary training for 4 pre and 4 post doctoral scientists at the forefront of research related to the molecular and physiological basis of vascular disease and to develop a clear understanding of molecular, cellular, and physiological mechanisms that maintain health of the vasculature. The program has specific features and dedicated components to address two emerging critical needs in current cardiovascular research: 1) to provide first-rate basic science laboratory training for clinical M.D.'s (residents) to form the basis for their careers as future clinician- investigators studying the cellular and molecular basis of cardiovascular diseases relevant to their clinical disciplines, and 2) to expose pre- and post-doctoral Ph.D. trainees In basic research to clinical cardiovascular pathophysiology to provide a disease-related framework for their training. To accomplish these goals we will 1) take advantage of the multidisciplinary and highly interactive environment within the OVID and at the University of Maryland Baltimore campus to provide multidisciplinary in thrombosis, vascular biology, stem cell biology, immunology and inflammation, 2) provide comprehensive and state-of-the-art scientific training experience for clinical trainees by establishing links with the outstanding clinical faculty at the University of Maryland and with the appropriate residency training programs 3) Provide appropriate clinical experience to our pre- and post-doctoral trainees in basic research by designing both didactic and hands on components guided by both PhD and MD faculty 4) Aid all of our trainees in their path to independence with regard to obtaining extramural funding and making the critical transition from trainee to mentored independent investigators. The training program has an excellent training record of producing productive and funded scientists at academic institutions and active researchers and leaders within the Biotechnology Industry. 4 pre and 4 postdoctoral trainees can choose from 21 mentors in seven departments. The training program offers unique didactic component that provides trainees with state-of-the art knowledge in Vascular and Stem Cell Biology and Clinical Cardiovascular Disease, vigorous and unique seminar programs, and skills courses that ensure their success in a competitive science environment.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007698-20
Application #
8320193
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Mondoro, Traci
Project Start
1991-07-01
Project End
2014-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
20
Fiscal Year
2012
Total Cost
$220,085
Indirect Cost
$26,410
Name
University of Maryland Baltimore
Department
Surgery
Type
Schools of Medicine
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Cheng, Emily; Whitsett, Timothy G; Tran, Nhan L et al. (2015) The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion. Mol Cancer Res 13:575-83
Siefert, S A; Chabasse, C; Mukhopadhyay, S et al. (2014) Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice. J Thromb Haemost 12:1706-16
Warren, Kristi J; Iwami, Daiki; Harris, Donald G et al. (2014) Laminins affect T cell trafficking and allograft fate. J Clin Invest 124:2204-18
Strickland, Dudley K; Au, Dianaly T; Cunfer, Patricia et al. (2014) Low-density lipoprotein receptor-related protein-1: role in the regulation of vascular integrity. Arterioscler Thromb Vasc Biol 34:487-98
Harris, Donald G; Quinn, Kevin J; Dahi, Siamak et al. (2014) Lung xenotransplantation: recent progress and current status. Xenotransplantation 21:496-506
Brinkman, C Colin; Burrell, Bryna E; Iwami, Daiki et al. (2013) Anatomy of tolerance. Curr Opin Organ Transplant 18:393-401
Craig, Julie; Mikhailenko, Irina; Noyes, Nathaniel et al. (2013) The LDL receptor-related protein 1 (LRP1) regulates the PDGF signaling pathway by binding the protein phosphatase SHP-2 and modulating SHP-2- mediated PDGF signaling events. PLoS One 8:e70432
Muratoglu, Selen C; Belgrave, Shani; Hampton, Brian et al. (2013) LRP1 protects the vasculature by regulating levels of connective tissue growth factor and HtrA1. Arterioscler Thromb Vasc Biol 33:2137-46
Porter, Holly A; Perry, Anthony; Kingsley, Chris et al. (2013) IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors. Cancer Lett 338:239-48
Dorsey, Nicolas J; Chapoval, Svetlana P; Smith, Elizabeth P et al. (2013) STAT6 controls the number of regulatory T cells in vivo, thereby regulating allergic lung inflammation. J Immunol 191:1517-28

Showing the most recent 10 out of 38 publications